IL10 and neoplasm: We previously reported that JC-001 down-regulates systemic Th17-mediated immunity in both Hepa 1-6 and LLC1 immunocompetent tumor models and up-regulates IL-10 secretion and down-regulates IL-17A in conditioned medium from co-cultured tumor cells and splenocytes.